Mayank Verma, M.D., Ph.D. Titles and Appointments Assistant Professor Schools Medical School Departments Pediatrics You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Mayank Verma, M.D., Ph.D., is an Assistant Professor in the Department of Pediatrics at UT Southwestern Medical Center. Dr. Verma earned his medical degree and a doctorate in integrative biology and physiology at the University of Minnesota Medical School. He completed his residency in child neurology at UT Southwestern Medical Center and then served as a pediatric neurology fellow in the Minassian Lab. He completed a research fellowship in gene therapy as part of his child neurology basic neuroscience pathway under Berge Minassian, M.D. Dr. Verma joined the UT Southwestern faculty in 2025. He is a physician-scientist who is involved in preclinical and translational studies focusing on progressive myoclonic epilepsy and glycogen storage disorders. His lab studies progressive myoclonic epilepsy and neuronal glycogen storage disorders, which are considered rare neurological diseases that have no treatment. As a scientist, he works to translate discoveries from animal models into improved natural history and biomarker studies, with the ultimate goal of developing gene therapy clinical trials and the tools needed to effectively treat children with neurological diseases. Dr. Verma’s clinical focus includes pediatric epilepsies, pediatric neuromuscular disorders, and neurogenetic diseases. Dr. Verma has delivered numerous presentations and has published and co-authored many articles, reviews, and book chapters. His professional affiliations include Child Neurology Society. Education Medical School (2025), Medicine Publications Generation of Friedreich’s ataxia induced pluripotent stem cells carrying the FXN c.165 + 5G>C splicing mutation Yameogo P, Gerhart BJ, Sentmanat MF, Neilson A, Cui X, Verma M, Lynch DR, Napierala JS, Napierala M Stem Cell Research 2026 Jun 93 Lafora disease gene therapy: EPM2A but not EPM2B overexpression results in Lafora body formation Alao EO, Sheibani M, Wu J, Marriam U, Evans D, Kasiri S, Verma M, Nitschke S, Nitschke F, Gray SJ, Mitra S, Minassian BA Neurotherapeutics 2026 Mar 23 Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora Disease Muccioli L, Ganceviciute B, Becker F, Minardi R, Tappatà M, Bachhuber F, Alkhatib M, Cirak S, Weishaupt J, Verma M, Tumani H, Wagner J, Messahel S, Nitschke F, Minassian BA, Bisulli F, Brenner D Neurology: Genetics 2025 Dec 11 e200319 Autosomal Recessive Cerebellar Ataxias: Translating Genes to Therapies Fogel BL, Klopstock T, Lynch DR, Maltecca F, Verma M, Minassian BA, Platt FM, Gonçalves DF, Puccio H, Roos A, Synofzik M Annals of Neurology 2025 Sep 98 448-470 Focused ultrasound widely broadens AAV-delivered Cas9 distribution and activity Gumusgoz E, Kasiri S, Youssef I, Verma M, Chopra R, Villarreal Acha D, Wu J, Marriam U, Alao E, Chen X, Guisso DR, Gray SJ, Shah BR, Minassian BA Gene Therapy 2025 May 32 237-245 Protocol for the three-dimensional analysis of rodent skeletal muscle Karthikeyan S, Asakura Y, Verma M, Asakura A STAR Protocols 2025 Mar 6 Glycogen synthase GYS1 overactivation contributes to glycogen insolubility and malto-oligoglucan-associated neurodegenerative disease Nitschke S, Montalbano AP, Whiting ME, Smith BH, Mukherjee-Roy N, Marchioni CR, Sullivan MA, Zhao X, Wang P, Mount H, Verma M, Minassian BA, Nitschke F EMBO Journal 2025 Mar 44 1379-1413 Three-dimensional imaging studies in mice identify cellular dynamics of skeletal muscle regeneration Collins BC, Shapiro JB, Scheib MM, Musci RV, Verma M, Kardon G Developmental cell 2024 Jun 59 1457-1474.e5 Myofiber-type-dependent ‘boulder’ or ‘multitudinous pebble’ formations across distinct amylopectinoses Mitra S, Chen B, Shelton JM, Nitschke S, Wu J, Covington L, Dear M, Lynn T, Verma M, Nitschke F, Fuseya Y, Iwai K, Evers BM, Minassian BA Acta Neuropathologica 2024 Jun 147 CSTB gene replacement improves neuroinflammation, neurodegeneration and ataxia in murine type 1 progressive myoclonus epilepsy Gumusgoz E, Kasiri S, Verma M, Wu J, Villarreal Acha D, Marriam U, Fyffe-Maricich S, Lin A, Chen X, Gray SJ, Minassian BA Gene Therapy 2024 May 31 234-241 Results 1-10 of 32 1 2 3 4 Next Last Books Featured Books Unverricht Lundborg Disease. In Handbook of Pediatric Epilepsy Case Studies, Second Edition Verma M, Minassian BA, Andrade DM (2023). Boca Raton, CRC Press
